Search alternatives:
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search)
a latest » a latent (Expand Search), _ latest (Expand Search), _ latent (Expand Search)
Showing 101 - 120 results of 16,813 for search '(( via ((a decrease) OR (larger decrease)) ) OR ( ((a largest) OR (a latest)) decrease ))', query time: 0.97s Refine Results
  1. 101
    Hr-GAL1 and 3 decreases intracellular galectin-1 and -3 level via exocytosis and proteasomal degradation.

    Hr-GAL1 and 3 decreases intracellular galectin-1 and -3 level via exocytosis and proteasomal degradation. by Anna Hillenmayer (12280007)

    Published 2022
    Save to List
    Saved in:
  2. 102
    Toluidine blue histology of cMSC constructs for initial chondrogenic screening.

    Toluidine blue histology of cMSC constructs for initial chondrogenic screening. by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 103
    Transfection rates increase with decreasing IEC density.

    Transfection rates increase with decreasing IEC density. by Chantal Ernst (9953921)

    Published 2024
    Save to List
    Saved in:
  4. 104
    Decrease in apoptosis in the ischemic myocardium.

    Decrease in apoptosis in the ischemic myocardium. by Laura A. Scrimgeour (9367459)

    Published 2020
    “…<p>There is an increase seen in JNK, pBAD, and pBAD/BAD with a decrease in pBCL-2, pBCL-2/BCL-2, and Caspase 3. …”
    Save to List
    Saved in:
  5. 105
    Su(H) and RBPJ AOS variants decrease DNA binding.

    Su(H) and RBPJ AOS variants decrease DNA binding. by Ellen K. Gagliani (11478756)

    Published 2022
    Save to List
    Saved in:
  6. 106
    Decreased expression of V-ATPase upon the siRNA transfection.

    Decreased expression of V-ATPase upon the siRNA transfection. by Manisha Naskar (2613763)

    Published 2023
    Save to List
    Saved in:
  7. 107
    Decreased expression of ATG5 upon the siRNA transfection.

    Decreased expression of ATG5 upon the siRNA transfection. by Manisha Naskar (2613763)

    Published 2023
    Save to List
    Saved in:
  8. 108
    Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX

    Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in inf... by Sara Gonia (14132166)

    Published 2024
    “…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”
    Save to List
    Saved in:
  9. 109
    Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX

    Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in inf... by Sara Gonia (14132166)

    Published 2024
    “…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”
    Save to List
    Saved in:
  10. 110
    Exposure to exogenous antioxidants prior to osmotic stress decreases tardigrade survival.

    Exposure to exogenous antioxidants prior to osmotic stress decreases tardigrade survival. by Amanda L. Smythers (9077730)

    Published 2024
    Save to List
    Saved in:
  11. 111
    Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity.

    Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

    Published 2023
    Save to List
    Saved in:
  12. 112
    Image8_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image8_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  13. 113
    Image10_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image10_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  14. 114
    Table1_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.DOCX

    Table1_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.DOCX by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  15. 115
    Image9_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image9_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  16. 116
    Image5_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image5_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  17. 117
    Image12_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image12_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  18. 118
    Image4_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image4_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  19. 119
    Image7_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image7_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:
  20. 120
    Image6_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image6_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    Save to List
    Saved in:

Search Tools: